Pain is something we all experience at some time in our lives. Acute pain following injury serves as warning signal, but chronic pain, as occurs in cancer, arthritis and other conditions, serves no physical purpose, negatively impacts quality of life and can be very difficult to manage.
This webinar will explain the science behind acute and chronic pain. Neuroscientists, clinicians and patient advocates will discuss the nervous system mechanisms that underlie pain, approaches to developing new pain therapies, the human and economic impact of pain, and the federal investment in pain research.
Speakers: Allan Basbaum, PhD<http://www.brainfacts.org/sensing-thinking-behaving/senses-and-perception/articles/2016/the-neuroscience-of-pain-translating-science-to-the-patient-020416/#basbaum>
Allan Basbaum is professor and chair of the Department of Anatomy at the University of California, San Francisco. His research addresses the molecular mechanisms that underlie the generation of persistent pain after tissue or nerve injury. Most recently, his laboratory has focused on novel approaches to overcoming the neurological consequences of peripheral nerve damage, by transplanting embryonic cortical inhibitory precursor cells into the spinal cord. The cells integrate into the host spinal cord and can ameliorate the persistent pain and itch associated with nerve damage. He served as Editor-in-Chief of PAIN, the journal of the International Association for the Study of Pain. Recently he was appointed Co-Chair of the Steering committee of the Intergovernmental Pain Research Coordinating Committee (IPRCC). He is a member of the American Academy of Arts and Sciences, the American Association for the Advancement of Science, the Institute of Medicine and is a fellow of the Royal Society in the UK.
Christin Veasley is the co-founder and director of the Chronic Pain Research Alliance (CPRA). With the ultimate goal of advancing timely diagnoses and effective evidence-based medical management for those living with multiple pain diagnoses, the CPRA works to promote rigorous pain research, translate research findings into educational programs for medical-scientific professionals and patients, and drive industry development of safe and effective treatments. Christin also lives with life-altering chronic pain that resulted from a car accident in her teens, and is one of few advocates working to increase the national investment in and acceleration of pain research.
Michael Rowbotham is a clinical neurologist and pain researcher at UCSF, and directs the Research Institute at CPMC in San Francisco. For the past 30 years, his research has focused on the mechanisms of neuropathic pain, herpes zoster and post-herpetic neuralgia (PHN), clinical trials methodology, transparency in clinical trials reporting, human experimental pain models, and treatment studies of opioids, topical local anesthetics, gabapentin, and numerous compounds early in development. He has actively mentored more than 25 pre- and post-doctoral students. He is active in the Analgesic Clinical Trial Innovations, Opportunities, and Networks (ACTION) public-private partnership with the FDA. His work on behalf of the International Association for the Study of Pain (IASP) spans 20 years, and he is currently Treasurer.
To register and listen to this FREE webinar, visit: http://www.brainfacts.org/sensing-thinking-behaving/senses-and-perception/articles/2016/the-neuroscience-of-pain-translating-science-to-the-patient-020416/